BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 2003-2011
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.2003
Table 1 Univariate analysis of the patients with different prognoses
Factor
Classify
Survival (n = 50)
Death (n = 10)
χ2
P value
SexMale34 (68.00)6 (60.00)0.2400.624
Female16 (32.00)4 (40.00)
Age> 60 yr21 (42.00)7 (70.00)2.6250.105
Admidia 60 yr29 (58.00)3 (30.00)
Bommann classificationI-II mold35 (70.00)4 (40.00)3.2970.069
III-IV mold15 (30.00)6 (60.00)
Histological typePoorly differentiated30 (60.00)1 (10.00)10.1410.006
Moderately differentiated11 (22.00)3 (30.00)
Well-differentiated9 (18.00)6 (60.00)
Tumor size≤ 5 cm38 (76.00)2 (20.00)11.760< 0.001
> 5 cm12 (24.00)8 (80.00)
TNM by stagesI-II designated time35 (70.00)1 (10.00)12.500< 0.001
III-IV designated time15 (30.00)9 (90.00)
Vascular invasionHave13 (26.00)6 (60.00)4.4520.035
Not have37 (74.00)4 (40.00)
Postoperative adjuvant chemoradiation therapyNot have16 (32.00)8 (80.00)8.0000.005
Have34 (68)2 (20)
Lymphatic metastasisHave10 (20)3 (30)0.4910.483
Not have40 (80)7 (70)


Write to the Help Desk